Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Long-Term Persistence of Mixed Full Donor Chimerism after Double Cord Blood Transplantation. Example of Tolerance in Allogeneic Hematopoietic Cell Transplantation Setting

Carole Saison, Virginie Mathias, Marie Balsat, Fiorenza Barraco, Sophie Ducastelle, Catherine Giannoli, Hélène Labussière-Wallet, Dan Adrian Luscalov, Philippe Moskovtchenko, Valerie Dubois, Mauricette Michallet

Blood (2022) 140 (Supplement 1): 12861–12862.

https://doi.org/10.1182/blood-2022-159961

Published: 2022

Journal Articles

HLA-B leader and survivorship after HLA-mismatched unrelated donor transplantation

Effie W. Petersdorf, Philip Stevenson, Mats Bengtsson, Dianne De Santis, Valerie Dubois, Ted Gooley, Mary Horowitz, Katharine Hsu, J. Alejandro Madrigal, Mari Malkki, Caroline McKallor, Yasuo Morishima, Machteld Oudshoorn, Stephen R. Spellman, Jean Villard, Mary Carrington

Blood (2020) 136 (3): 362–369.

https://doi.org/10.1182/blood.2020005743

Published: 2020

Includes: Supplemental data

Journal Articles

CP-CML Seems Related to Specific HLA Subtypes and the HLA DRB1 07 Allele Might Identify a Subgroup of Newly Diagnosed CP-CML Patients on Imatinib First-Line of Better Prognosis

Franck-Emmanuel Nicolini, MD PhD, Stéphanie Désilets, MD, Sandrine Hayette, PhD, Isabelle Tigaud, MD, Liliana Vila, Stephane Morisset, Stat, Mohamad Sobh, PharmD, Mauricette Michallet, MD PhD, Valerie Dubois, MD

Blood (2018) 132 (Supplement 1): 5436.

https://doi.org/10.1182/blood-2018-99-117733

Published: 2018

Journal Articles

Association Between Multiple Mismatches at the HLA-DPB1 and DRB3/4/5 Genes and Adverse Outcomes in HLA-a, -B, -C, -DRB1 and -DQB1 Identical Hematopoietic Stem Cell Transplantation: A Study on Behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC) and the Francophone Society for Histocompatibility and Immunogenetics (SFHI)

Blood (2016) 128 (22): 4660.

https://doi.org/10.1182/blood.V128.22.4660.4660

Published: 2016

Journal Articles

Single HLA Mismatch Unrelated Donor Allogeneic Stem Cell Transplantation in Caucasian Recipients: Outcomes in HLA-A, -B, -C, -DRB1 and -DQB1 Mismatch Hematopoietic Stem Cell Transplantation: A Study on Behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC) and the Francophone Society for Histocompatibility and Immunogenetics (SFHI)

Blood (2016) 128 (22): 3474.

https://doi.org/10.1182/blood.V128.22.3474.3474

Published: 2016

Journal Articles

Matching for the nonconventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHD

Raphael Carapito, Nicolas Jung, Marius Kwemou, Meiggie Untrau, Sandra Michel, Angélique Pichot, Gaëlle Giacometti, Cécile Macquin, Wassila Ilias, Aurore Morlon, Irina Kotova, Petya Apostolova, Annette Schmitt-Graeff, Anne Cesbron, Katia Gagne, Machteld Oudshoorn, Bronno van der Holt, Myriam Labalette, Eric Spierings, Christophe Picard, Pascale Loiseau, Ryad Tamouza, Antoine Toubert, Anne Parissiadis, Valérie Dubois, Xavier Lafarge, Myriam Maumy-Bertrand, Frédéric Bertrand, Luca Vago, Fabio Ciceri, Catherine Paillard, Sergi Querol, Jorge Sierra, Katharina Fleischhauer, Arnon Nagler, Myriam Labopin, Hidetoshi Inoko, Peter A. von dem Borne, Jürgen Kuball, Masao Ota, Yoshihiko Katsuyama, Mauricette Michallet, Bruno Lioure, Régis Peffault de Latour, Didier Blaise, Jan J. Cornelissen, Ibrahim Yakoub-Agha, Frans Claas, Philippe Moreau, Noël Milpied, Dominique Charron, Mohamad Mohty, Robert Zeiser, Gérard Socié, Seiamak Bahram

Blood (2016) 128 (15): 1979–1986.

https://doi.org/10.1182/blood-2016-05-719070

Published: 2016

Includes: Supplemental data

Journal Articles

Mixed Chimerism at Three Months after Allogeneic Hematopoietic Stem Cell Transplantation Is a Significant Predictor of Disease Relapse in High-Risk Acute Myeloid Leukemia Patients in First Complete Remission

Mauricette Michallet, MD PhD, Mohamad Sobh, PharmD, Hélène Labussière-wallet, MD, Marie Balsat, MD, Caroline Lejeune, MD, Isabelle Mollet, Tech., Philippe Moskovtchenko, Tech., Xavier Thomas, Fiorenza Barraco, MD, Valérie Mialou, Tech., Valérie Dubois, MD, Franck E. Nicolini, MD PhD

Blood (2015) 126 (23): 2577.

https://doi.org/10.1182/blood.V126.23.2577.2577

Published: 2015

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia Patients in First Complete Remission: Significant Impact of the Interval Between Diagnosis and Transplantation on Different Outcomes

Stéphanie Ducreux, PharmD, Mohamad Sobh, PharmD, Stéphane Morisset, Stat, Marie Balsat, MD, Xavier Thomas, Caroline Lejeune, MD, Sophie Ducastelle-Leprêtre, MD, Fiorenza Barraco, MD, Hélène Labussière-wallet, MD, Franck E. Nicolini, MD PhD, Mauricette Michallet, MD PhD, Valérie Dubois, MD

Blood (2015) 126 (23): 5517.

https://doi.org/10.1182/blood.V126.23.5517.5517

Published: 2015

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation from Unrelated Peripheral Blood or Bone Marrow Donors: The Impact of HLA Matching Including HLA-DPB1 Allele in a Multivariable Risk Model

Mauricette Michallet, MD PhD, Mohamad Sobh, PharmD, Hélène Labussière-wallet, MD, Marie Balsat, MD, Caroline Lejeune, MD, Sophie Ducastelle-Leprêtre, MD, Xavier Thomas, Catherine Giannoli, Philippe Moskovtchenko, Tech., Fiorenza Barraco, MD, Franck E. Nicolini, MD PhD, Valérie Dubois, MD

Blood (2015) 126 (23): 3213.

https://doi.org/10.1182/blood.V126.23.3213.3213

Published: 2015

Journal Articles

Matching of MHC Class I Chain-Related Genes a and B Is Associated with Reduced Incidence of Severe Acute Graft-Versus-Host Disease after Unrelated Hematopoietic Stem Cell Transplantation

Blood (2014) 124 (21): 664.

https://doi.org/10.1182/blood.V124.21.664.664

Published: 2014

Journal Articles

Therapeutic Management of Acute Myeloid Leukemia Patients after Stratification on Age, Prognosis and Allogeneic Hematopoietic Stem Cell Transplantation Eligibility

Mauricette Michallet, MD PhD, Mohamad Sobh, Pharm.M., Mohamed Elhamri, PhD, Jeremy Monfray, CRA, Helene Labussiere-Wallet, MD, Sandrine Hayette, PhD, Isabelle Tigaud, MD, Lila Gilis, MD, Laure L Lebras, MD, Fiorenza Barraco, MD, Sophie Ducastelle, MD, Adriana Plesa, MD, Valerie Dubois, Franck E. Nicolini, MD PhD, Xavier Thomas, MD PhD

Blood (2014) 124 (21): 3691.

https://doi.org/10.1182/blood.V124.21.3691.3691

Published: 2014

Journal Articles

Unrelated Alternative Donor Transplants for Severe Acquired Aplastic Anemia: A 12-Year Retrospective Study from the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC)

Raynier Devillier, MD, Jean-Hugues Dalle, PhD MD, Laurence Clement, Noel Milpied, MD PhD, Patrice Chevallier, MD PhD, Yves Bertrand, MD, Mauricette Michallet, MD PhD, Ibrahim Yakoub-Agha, MD PhD, Jean-Yves Cahn, MD PhD, Marc Bernard, MD, Pascale Loiseau, Valerie Dubois, Gerard Socie, MD PhD, Regis Peffault de Latour, MD PhD

Blood (2014) 124 (21): 2945.

https://doi.org/10.1182/blood.V124.21.2945.2945

Published: 2014

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Therapy-Related Acute Myeloid Leukemia

Mauricette Michallet, MD PhD, Mohamad Sobh, Pharm.M., Jeremy Monfray, CRA, Hélène Labussière-Wallet, MD, Sandrine Hayette, PhD, Isabelle Tigaud, MD, Mohamed Elhamri, PhD, Lila Gilis, MD, Laure L Lebras, MD, Fiorenza Barraco, MD, Sophie Ducastelle, MD, Valerie Dubois, Franck E. Nicolini, MD PhD, Xavier Thomas, MD PhD

Blood (2014) 124 (21): 2542.

https://doi.org/10.1182/blood.V124.21.2542.2542

Published: 2014

Journal Articles

A Significant Early Detection Of Poor Outcome In Acute Myeloid Leukemia Patients Having a Minimal Residual Disease Using Multiparameter Flow Cytomerty Combined To Mixed Chimerism At Three Months After Allogeneic Hematopoietic Stem Cell Transplantation

Florence Beckerich, MD, Mohamad Sobh, Pharm.M., Stephane Morisset, Stat., Adriana Plesa, MD, Valerie Dubois, MD, Isabelle Mollet, Helene Labussiere, MD, Lila Gilis, MD, Sophie Ducastelle, MD, Oriane Le Borgne, CRA, Jeremy Monfray, CRA, Fiorenza Barraco, MD, Isabelle Tigaud, MD, Xavier Thomas, MD, Franck E. Nicolini, MD, PhD, Mauricette Michallet, MD, PhD

Blood (2013) 122 (21): 4639.

https://doi.org/10.1182/blood.V122.21.4639.4639

Published: 2013

Journal Articles

HLA-DRB4 Mismatch Is Associated with Worse Outcomes in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies

Marie Y. Detrait, MD, Ibrahim Yakoub-Agha, MD, PhD, Valerie Dubois, MD, Françoise Dufossé, Myriam Labalette, Mohamad Sobh, Pharm.M., Stéphane Morisset, Stat., Nathalie Tedone, CRA, Sylvie Rey, Elodie Morais, Mauricette Michallet, MD, PhD

Blood (2012) 120 (21): 4540.

https://doi.org/10.1182/blood.V120.21.4540.4540

Published: 2012

Journal Articles

High Impact of Matching Score On Different HSCT Outcomes After Single and Double Umbilical Cord Blood Transplantation for Hematological Malignancies

Mauricette Michallet, MD, PhD, Mohamad Sobh, Pharm.M., Stephane Morisset, Stat., Hélène Labussière-Wallet, MD, Marie Y. Detrait, MD, Valerie Dubois, MD, Jean-Paul Bourgeot, Sophie Ducastelle, MD, Fiorenza Barraco, MD, Youcef Chelghoum, MD, Valerie Mialou, Valérie Chapelle, Sothiny Sar, Olivier Hequet, MD, Xavier Thomas, MD, Franck E. Nicolini, MD, PhD, Yves Bertrand

Blood (2012) 120 (21): 1992.

https://doi.org/10.1182/blood.V120.21.1992.1992

Published: 2012

Journal Articles

The Impact of Anti-HLA Antibodies on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes After Reduced-Intensity Conditioning Regimens

Marie Y. Detrait, MD, Valerie Dubois, MD, Mohamad Sobh, Pharm.M., Stephane Morisset, Stat., Nathalie Tedone, CRA, Franck E. Nicolini, MD, PhD, Helene Labussiere, MD, Lilia Gillis, MD, Fiorenza Barraco, MD, Giovanna Cannas, MD, Sophie Ducastelle, MD, Jihane Fattoum, MD, PhD, Xavier Thomas, MD, PhD, Youcef Chelghoum, MD, Mauricette Michallet

Blood (2011) 118 (21): 2038.

https://doi.org/10.1182/blood.V118.21.2038.2038

Published: 2011

Journal Articles

Highly Significant Impact of HLA-DRB3 and HLA-DRB4 Matching on Different Unrelated Allo-HSCT Outcomes: New Perspectives in the Unrelated Donor Selection

Marie Y. Detrait, MD, Valerie Dubois, MD, Mohamad Sobh, Pharm.M., Stephane Morisset, Stat., Franck E. Nicolini, MD, PhD, Helene Labussiere, MD, Fiorenza Barraco, MD, Giovanna Cannas, MD, Sophie Ducastelle, MD, Jihane Fattoum, MD, PhD, Xavier Thomas, MD, PhD, Youcef Chelghoum, MD, Nathalie Tedone, CRA, Sylvie Rey, Mauricette Michallet

Blood (2011) 118 (21): 4481.

https://doi.org/10.1182/blood.V118.21.4481.4481

Published: 2011

Journal Articles

A New Score to Determine the Probability of Finding An HLA Identical Unrelated Donor: A Promising Efficient Time and Cost Saving Method,

Valerie Dubois, MD, Marie L Balere, Stat., Mohamad Sobh, Pharm.M., Stephane Morisset, Stat., Helene Labussiere, MD, Marie Y. Detrait, MD, Franck E. Nicolini, MD, PhD, Sylvie Rey, Valerie Mialou, Yves Bertrand, Mauricette Michallet

Blood (2011) 118 (21): 4188.

https://doi.org/10.1182/blood.V118.21.4188.4188

Published: 2011

Journal Articles

Double Cord Blood Units Allogeneic Transplantation for Hematological Malignancies: Study of the “3 Partners” Matching Variables on Transplant Outcomes

Mauricette Michallet, Mohamad Sobh, Pharm.M., Stephane Morisset, Stat., Helene Labussiere, MD, Marie Y. Detrait, MD, Franck E. Nicolini, MD, PhD, Sophie Ducastelle, MD, Fiorenza Barraco, MD, Xavier Thomas, MD, PhD, Nathalie Tedone, CRA, Youcef Chelghoum, MD, Jihane Fattoum, MD, PhD, Isabelle Mollet, Valerie Dubois, MD

Blood (2011) 118 (21): 3111.

https://doi.org/10.1182/blood.V118.21.3111.3111

Published: 2011

NARROW

Long-Term Persistence of Mixed Full Donor Chimerism after Double Cord Blood Transplantation. Example of Tolerance in Allogeneic Hematopoietic Cell Transplantation Setting

HLA-B leader and survivorship after HLA-mismatched unrelated donor transplantation

CP-CML Seems Related to Specific HLA Subtypes and the HLA DRB1 07 Allele Might Identify a Subgroup of Newly Diagnosed CP-CML Patients on Imatinib First-Line of Better Prognosis

Matching for the nonconventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHD

Mixed Chimerism at Three Months after Allogeneic Hematopoietic Stem Cell Transplantation Is a Significant Predictor of Disease Relapse in High-Risk Acute Myeloid Leukemia Patients in First Complete Remission

Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia Patients in First Complete Remission: Significant Impact of the Interval Between Diagnosis and Transplantation on Different Outcomes

Allogeneic Hematopoietic Stem Cell Transplantation from Unrelated Peripheral Blood or Bone Marrow Donors: The Impact of HLA Matching Including HLA-DPB1 Allele in a Multivariable Risk Model

Matching of MHC Class I Chain-Related Genes a and B Is Associated with Reduced Incidence of Severe Acute Graft-Versus-Host Disease after Unrelated Hematopoietic Stem Cell Transplantation

Therapeutic Management of Acute Myeloid Leukemia Patients after Stratification on Age, Prognosis and Allogeneic Hematopoietic Stem Cell Transplantation Eligibility

Unrelated Alternative Donor Transplants for Severe Acquired Aplastic Anemia: A 12-Year Retrospective Study from the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC)

Allogeneic Hematopoietic Stem Cell Transplantation for Therapy-Related Acute Myeloid Leukemia

A Significant Early Detection Of Poor Outcome In Acute Myeloid Leukemia Patients Having a Minimal Residual Disease Using Multiparameter Flow Cytomerty Combined To Mixed Chimerism At Three Months After Allogeneic Hematopoietic Stem Cell Transplantation

HLA-DRB4 Mismatch Is Associated with Worse Outcomes in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies

High Impact of Matching Score On Different HSCT Outcomes After Single and Double Umbilical Cord Blood Transplantation for Hematological Malignancies

The Impact of Anti-HLA Antibodies on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes After Reduced-Intensity Conditioning Regimens

Highly Significant Impact of HLA-DRB3 and HLA-DRB4 Matching on Different Unrelated Allo-HSCT Outcomes: New Perspectives in the Unrelated Donor Selection

A New Score to Determine the Probability of Finding An HLA Identical Unrelated Donor: A Promising Efficient Time and Cost Saving Method,

Double Cord Blood Units Allogeneic Transplantation for Hematological Malignancies: Study of the “3 Partners” Matching Variables on Transplant Outcomes

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only